Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 821Question →

A 58-year-old woman presents to the outpatient clinic to review the results of a recent liver biopsy. She was evaluated last week for vague abdominal pain and weight loss, which prompted imaging and the subsequent biopsy. The pathology report confirms metastatic pancreatic adenocarcinoma. The physician is preparing to enter the exam room to deliver this serious news.

Arrange the following communication steps in the correct chronological order according to the standard framework for breaking bad news (e.g., SPIKES protocol), from first to last.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Arrange for a private setting, ask about the patient's understanding, inquire about detail preference, and then state the diagnosis clearly.
The correct sequence follows the widely accepted SPIKES protocol for delivering bad news. This structured approach begins with establishing a secure Setting, followed by assessing the patient's Perception of their illness, obtaining an Invitation to share the information, and finally delivering the Knowledge clearly.

Step-by-Step Solution

1
Identify the clinical objective in this encounter.
The physician must deliver a life-limiting diagnosis of metastatic cancer in a compassionate, structured manner.
Breaking bad news is a sensitive skill that requires minimizing patient trauma and maximizing comprehension.
2
Recall a structured communication framework for this scenario.
The SPIKES protocol (Setting, Perception, Invitation, Knowledge, Emotions, Strategy) is the standard approach.
Using a validated framework ensures no critical preparatory steps are missed before delivering the news.
3
Sequence the provided communication steps according to the chosen framework.
First establish the Setting, then assess Perception, then obtain an Invitation, and finally deliver the Knowledge.
This stepwise approach aligns directly with the natural flow of the SPIKES protocol.

Key Concept

Delivering bad news using the SPIKES protocol
Question 822Question →

Match each patient scenario involving advanced illness with the most appropriate next step in palliative symptom management, taking into account their underlying comorbidities.

Click a left item, then click its matching right item

Items

A 64-year-old hospice patient with end-stage renal disease and severe metastatic bone pain requires initiation of a continuous, long-acting opioid.
A 72-year-old actively dying patient with a known history of severe closed-angle glaucoma develops noisy, gurgling breathing (terminal secretions).
A 58-year-old with advanced ovarian cancer and a complete malignant small bowel obstruction has severe colicky abdominal pain and intractable vomiting.
A 79-year-old actively dying patient with a long-standing history of Parkinson disease develops severe hyperactive delirium and aggressive behavior.

Matches

Show answer & explanation

Answer

Match the ESRD patient to fentanyl/methadone, the glaucoma patient to repositioning (avoiding antimuscarinics), the complete bowel obstruction patient to octreotide/corticosteroids (avoiding prokinetics), and the Parkinson disease patient to quetiapine/midazolam (avoiding haloperidol).
Each correct match pairs an end-of-life symptom with the appropriate modified intervention that safely circumvents the patient's specific comorbidity-related contraindication.

Step-by-Step Solution

1
Analyze the patient with end-stage renal disease (ESRD) requiring long-acting opioids.
Identify that hepatically cleared opioids must be used.
Accumulation of morphine's renally cleared active metabolites can cause severe opioid-induced neurotoxicity.
2
Evaluate the patient with terminal secretions and closed-angle glaucoma.
Determine that antimuscarinic agents are contraindicated.
Antimuscarinics (such as scopolamine and atropine) cause pupillary dilation, which can trigger a painful acute angle-closure glaucoma crisis.
3
Assess the patient with complete malignant bowel obstruction.
Identify that prokinetic agents must be stopped and antisecretory agents started.
Metoclopramide stimulates peristalsis against a mechanical block, risking perforation; octreotide reduces secretions and bowel distention.
4
Review the agitated patient with Parkinson disease.
Conclude that typical antipsychotics must be avoided.
Haloperidol's strong dopamine antagonism will severely exacerbate Parkinsonian symptoms; quetiapine is a safer alternative.

Key Concept

Advanced symptom management in palliative care requires careful modification of standard protocols based on patient-specific comorbidities that present absolute or relative contraindications.
Question 823Question →

An 81-year-old woman is evaluated on the medical ward on hospital day 3. She was admitted for severe aspiration pneumonia and sepsis. Her medical history is significant for advanced Alzheimer disease; she has been completely bedbound, doubly incontinent, and nonverbal for the past year. She currently requires high-flow oxygen, and her clinical trajectory suggests she may soon require mechanical ventilation if aggressive care is pursued. She does not have an advance directive or a legally appointed healthcare proxy.

The patient's daughter, who lives locally and visits her mother daily at the nursing facility, believes her mother would never have wanted her life artificially prolonged in her current state. She requests that the medical team focus exclusively on comfort measures. The patient's son, who lives in a different state and arrived this morning, vehemently disagrees. He insists that his mother is 'a fighter,' demands full resuscitation status, and requests the placement of a percutaneous endoscopic gastrostomy tube to prevent future aspiration. He states he will contact an attorney if everything possible is not done. In the state where the hospital is located, all adult children share equal priority in the surrogate hierarchy.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Request a clinical ethics committee consultation to help mediate the conflict and establish a consensus.

Answer

Request a clinical ethics committee consultation to help mediate the conflict and establish a consensus.
When there is a fundamental disagreement between co-equal surrogate decision-makers (in this case, two adult children) regarding the goals of care for an incapacitated patient, the medical team cannot unilaterally choose which surrogate to follow. Although the medical team may agree with the daughter's assessment that comfort-focused care is most appropriate for a patient with advanced Alzheimer disease, the daughter does not possess higher legal authority than her brother. The appropriate initial approach is to hold family meetings to facilitate consensus, typically with the assistance of a clinical ethics committee, palliative care specialists, or social workers. An ethics consultation can help clarify the patient's previously expressed values, mediate the interpersonal conflict, and guide the application of the substituted judgment standard.

Step-by-Step Solution

1
Identify the patient's capacity and advance directive status.
The patient lacks decision-making capacity due to advanced dementia and acute illness, and she has no advance directive or designated proxy.
This establishes the clinical and legal requirement for surrogate decision-makers.
2
Determine the legal status of the available surrogate decision-makers.
Both the daughter and the son are adult children, placing them at the exact same priority level in the default legal surrogate hierarchy.
Understanding the legal hierarchy prevents the medical team from inappropriately favoring one surrogate over another based on subjective criteria.
3
Assess the conflict and determine the appropriate dispute resolution mechanism.
Because co-equal surrogates fundamentally disagree on the goals of care, an ethics committee consultation is required.
Physicians cannot unilaterally break a tie between co-equal surrogates; formal mediation is the standard of care to help apply the principle of substituted judgment.

Key Concept

Management of conflicts between co-equal surrogate decision-makers regarding end-of-life care
Question 824Question →

A 45-year-old woman comes to the ambulatory clinic for a routine wellness evaluation. She reports feeling well and has no acute symptoms. Her medical history is notable for a deep vein thrombosis in her left lower extremity 3 years ago following a 12-hour flight. She was treated with oral anticoagulation for 6 months and currently takes no medications. She has never smoked and consumes alcohol occasionally. She menstruates regularly every 28 days. Her mother was diagnosed with breast cancer at age 50 and her maternal aunt was diagnosed with the same disease at age 55. The patient is highly concerned about her own risk of developing breast cancer. She had a screening mammogram 2 weeks ago that was interpreted as BI-RADS category 1 (negative). She has read about medications that can lower breast cancer risk and requests a prescription for preventive therapy. Vital signs and physical examination are within normal limits. Which of the following is the most appropriate response regarding chemoprevention for this patient?

Show answer & explanation

Answer: Counsel that pharmacologic breast cancer risk reduction is contraindicated

Answer

Counsel that pharmacologic breast cancer risk reduction is contraindicated
The correct response is to counsel the patient that pharmacologic breast cancer risk reduction is contraindicated. While this patient's strong family history places her at increased risk for breast cancer—prompting consideration for primary chemoprevention—her unique clinical profile eliminates all safe pharmacologic options. Tamoxifen is the only FDA-approved medication for breast cancer risk reduction in premenopausal women; however, as a Selective Estrogen Receptor Modulator (SERM), it carries a well-documented risk of venous thromboembolism. A prior history of deep vein thrombosis (DVT) is an absolute contraindication to its use. Other risk-reducing agents, such as raloxifene and aromatase inhibitors (e.g., anastrozole, exemestane), are strictly indicated for postmenopausal women. Therefore, with tamoxifen contraindicated by her DVT history and alternative agents contraindicated by her functioning ovaries, no pharmacologic option can be safely prescribed.

Step-by-Step Solution

1
Assess the patient's baseline risk for breast cancer.
The patient has a strong family history (two first-degree/second-degree relatives with early-onset breast cancer), placing her at increased risk and making her a potential candidate for primary chemoprevention.
Guidelines recommend discussing risk-reducing medications for women at high risk for breast cancer.
2
Evaluate the patient's menopausal status.
Regular 28-day menstrual cycles at age 45 indicate the patient is premenopausal.
Menopausal status dictates which chemopreventive agents can be safely and effectively utilized.
3
Identify absolute contraindications in the patient's medical history.
The patient has a history of deep vein thrombosis (DVT).
A history of venous thromboembolism is an absolute contraindication to Selective Estrogen Receptor Modulators (SERMs).
4
Synthesize data to determine the appropriate pharmacologic intervention.
Tamoxifen (the only agent for premenopausal women) is contraindicated due to DVT. Aromatase inhibitors are contraindicated due to premenopausal status.
Because no approved chemopreventive agent is safe for this specific patient, pharmacologic risk reduction is contraindicated.

Key Concept

Indications and contraindications for breast cancer chemoprevention
Estimated Time:1m 30s
Question 825Question →

A 68-year-old man with progressive amyotrophic lateral sclerosis is brought to the emergency department by emergency medical services due to worsening shortness of breath and lethargy over the past 24 hours. On arrival, he is obtunded and responsive only to painful stimuli. Vital signs show a heart rate of 110/min, blood pressure of 145/90 mm Hg, and respiratory rate of 28/min. Oxygen saturation is 82% on room air, and arterial blood gas analysis reveals a pH of 7.18 and a PaCO2 of 85 mm Hg. The patient lacks decision-making capacity. His wife, who is his legally designated healthcare proxy, is present. The electronic medical record contains a valid advance directive completed by the patient three months ago when he had full capacity. The document explicitly states he does not want endotracheal intubation or invasive mechanical ventilation under any circumstances, but he wishes to receive non-invasive positive pressure ventilation for symptom relief. The wife is tearful and states, "I know what the form says, but he was depressed when he signed it. I cannot lose him today. You must intubate him."

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate non-invasive positive pressure ventilation and decline the request for intubation

Answer

Initiate non-invasive positive pressure ventilation and decline the request for intubation
The most appropriate action is to honor the patient's explicitly documented wishes. When a patient loses decision-making capacity, an advance directive serves as their voice. Because the directive clearly addresses the current clinical scenario (refusing intubation but accepting non-invasive ventilation), the physician is ethically and legally obligated to follow it, even if the legally designated healthcare proxy disagrees. The proxy's role is to facilitate the patient's wishes, not to substitute their own preferences.

Step-by-Step Solution

1
Assess the patient's clinical status and capacity.
The patient is in acute hypercapnic respiratory failure, is obtunded, and lacks decision-making capacity.
Determining capacity is the first step in deciding who directs medical care.
2
Review available advance directives and identify the surrogate decision-maker.
A valid advance directive explicitly refuses intubation but accepts non-invasive positive pressure ventilation. The wife is the healthcare proxy.
When a patient lacks capacity, prior documented wishes guide care. The surrogate's role is to enforce those wishes, not override them.
3
Address the conflict between the surrogate's request and the advance directive.
The physician must honor the clear, applicable advance directive over the wife's emotional request for intubation.
A surrogate decision-maker must follow the principle of substituted judgment, meaning they must make the decision the patient would make. A clear advance directive represents the patient's voice.

Key Concept

An explicit, valid advance directive supersedes the conflicting wishes of a surrogate decision-maker or healthcare proxy.
Question 826Question →

A 48-year-old man with hyperlipidemia and a strong family history of premature coronary artery disease presents for a follow-up visit. He expresses skepticism about starting statin therapy, citing concerns he read online regarding muscular side effects. The physician decides to employ a structured Motivational Interviewing approach to counsel the patient. Arrange the following physician statements in the correct chronological sequence, reflecting the four foundational processes of Motivational Interviewing (Engaging, Focusing, Evoking, and Planning).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence follows the four processes of Motivational Interviewing: Engaging, Focusing, Evoking, and Planning.
Motivational Interviewing utilizes a strict, sequential four-process framework. First, the physician must Engage the patient to build trust and roll with initial resistance. Second, they Focus the conversation to define a shared, specific health agenda. Third, they Evoke the patient's internal reasons for change by resolving ambivalence and highlighting core values. Finally, when readiness is established, they move to Planning a specific, actionable course of treatment.

Step-by-Step Solution

1
Identify the statement that builds initial rapport and avoids confrontation.
The statement validating the patient's extensive reading represents 'Engaging'.
Before any medical advice can be given, the physician must establish a non-judgmental working alliance, especially with a skeptical patient.
2
Locate the statement that sets a collaborative agenda for the visit.
Asking permission to discuss cardiovascular risk represents 'Focusing'.
Once engaged, the physician must narrow the conversation to a specific target behavior or health goal to ensure the session is productive.
3
Find the statement that elicits the patient's internal motivation ('change talk').
Connecting the patient's goal of traveling with grandchildren to their cholesterol levels represents 'Evoking'.
True behavioral change is driven by internal values, not external pressure. The physician must evoke these reasons before discussing a plan.
4
Identify the statement that consolidates readiness into an actionable strategy.
Documenting when to take the statin and what symptoms to monitor represents 'Planning'.
Only after ambivalence is resolved and motivation is clear should the physician assist the patient in formulating a concrete action plan.

Key Concept

The Four Foundational Processes of Motivational Interviewing
Estimated Time:1m 30s
Question 827Question →

Match each patient statement regarding their health behaviors (representing a specific communication barrier) to the most appropriate initial physician counseling strategy.

Click a left item, then click its matching right item

Items

"I've tried quitting smoking three times already, but I always end up failing."
"Everyone in my family gets heart disease eventually, so there is no point in changing my diet."
"I stopped taking my blood pressure medication because I feel completely fine without it."
"The specialist told me I have heart failure, but I am pretty sure I am just tired from working too much."

Matches

Show answer & explanation

Answer

Statement 1 matches the confidence-building strategy; Statement 2 matches the strategy addressing family history risk; Statement 3 matches the strategy explaining asymptomatic conditions; Statement 4 matches the strategy exploring baseline understanding.
Each matching pair correctly pairs a specific communication barrier (low self-efficacy, fatalism, asymptomatic misconception, poor comprehension) with its evidence-based patient counseling response.

Step-by-Step Solution

1
Analyze the underlying barrier in the first statement.
Identified low self-efficacy and fear of failure.
To select a strategy that builds confidence and validates past effort.
2
Analyze the second statement.
Identified fatalism based on genetics or family history.
To select a strategy that empowers the patient by highlighting controllable factors.
3
Analyze the third statement.
Identified a misconception about symptom-disease correlation.
To select an educational strategy regarding silent, long-term conditions.
4
Analyze the fourth statement.
Identified denial or lack of comprehension regarding a severe diagnosis.
To select a strategy that assesses the patient's current knowledge before providing new facts.

Key Concept

Identifying specific patient barriers to change and tailoring communication strategies accordingly.
Question 828Question →

A 72-year-old man with New York Heart Association (NYHA) class IV heart failure is evaluated in the outpatient cardiology clinic. Despite maximally tolerated medical therapy, he experiences significant dyspnea at rest and has been hospitalized three times in the past four months for acute decompensation. During the visit, he states that he is exhausted from the frequent hospital admissions and wishes to transition to a care plan focused entirely on comfort at his home. His daughter, who accompanies him, supports this decision but asks the physician what specific requirements must be met for her father to receive home hospice services. The patient is fully alert, oriented, and engages appropriately in the discussion. Which of the following is an essential clinical criterion for this patient to enroll in hospice care?

Show answer & explanation

Answer: Physician certification of a life expectancy of 6 months or less

Answer

Physician certification of a life expectancy of 6 months or less
The correct answer is the certification of a life expectancy of 6 months or less. Hospice care is a specialized form of palliative care designed specifically for terminally ill patients. The primary eligibility criterion across the United States (based on Medicare guidelines) is that the patient's attending physician and the hospice medical director must certify that the patient has a life expectancy of 6 months or less, assuming the terminal illness runs its natural course.

Step-by-Step Solution

1
Identify the patient's primary goal of care.
The patient desires a transition to comfort-focused care at home, avoiding further hospitalizations.
Establishing the goal of care is the first step in determining appropriate palliative or hospice interventions.
2
Evaluate the patient's eligibility for hospice based on standard guidelines.
The patient must have a terminal prognosis of ≤6 months.
Under standard Medicare and clinical guidelines, hospice care requires a physician-certified life expectancy of 6 months or less.

Key Concept

Hospice Care Eligibility Criteria
Estimated Time:1m 0s
Question 829Question →

Match each end-of-life clinical scenario with the most appropriate targeted pharmacological intervention.

Click a left item, then click its matching right item

Items

A 75-year-old hospice patient with end-stage renal disease (not on dialysis) who develops severe resting dyspnea.
A 64-year-old patient with advanced ovarian cancer presenting with an inoperable complete malignant bowel obstruction, intractable nausea, and colicky pain.
A 70-year-old patient with metastatic prostate cancer on high-dose morphine who develops new-onset diffuse allodynia, myoclonus, and delirium.
An 82-year-old actively dying patient who is unresponsive and develops loud, gurgling respirations ('death rattle') that are distressing to the family.

Matches

Show answer & explanation

Answer

End-stage renal disease matches with fentanyl/methadone; malignant bowel obstruction matches with octreotide; opioid-induced neurotoxicity matches with opioid rotation and hydration; and terminal secretions match with glycopyrrolate.
Each match correctly pairs a complex end-of-life clinical scenario with its gold-standard palliative intervention based on pharmacokinetics and pathophysiology. Fentanyl is safe in renal failure, octreotide manages malignant bowel obstructions without stimulating motility, opioid rotation clears neurotoxic metabolites, and glycopyrrolate addresses terminal pooling of secretions.

Step-by-Step Solution

1
Identify the underlying cause of the palliative symptom or the specific pharmacological contraindication in each patient scenario.
Patient 1 requires dyspnea management but has renal failure. Patient 2 has a mechanical bowel obstruction. Patient 3 is exhibiting signs of opioid-induced neurotoxicity. Patient 4 is exhibiting pooling of oropharyngeal secretions.
Accurate etiology identification determines the choice of targeted pharmacological intervention.
2
Select the appropriate intervention that addresses the specific pathophysiological mechanism.
Fentanyl is selected for renal failure to prevent metabolite accumulation. Octreotide is selected to dry bowel secretions. Hydration and opioid rotation treat the neurotoxic metabolite buildup. Glycopyrrolate dries salivary secretions.
Matching the drug's mechanism of action and clearance pathway to the clinical scenario ensures safe and effective symptom relief.

Key Concept

Targeted pharmacological symptom management at the end of life requires integrating medication pharmacokinetics (e.g., avoiding morphine in renal failure) with the pathophysiology of specific terminal complications (e.g., using octreotide to reduce secretions in bowel obstruction).
Question 830Question →

Match each end-of-life clinical scenario or symptom with its most appropriate first-line pharmacologic intervention.

Click a left item, then click its matching right item

Items

Terminal dyspnea (air hunger) in an opioid-naive patient with end-stage chronic obstructive pulmonary disease.
Accumulation of noisy respiratory secretions ('death rattle') in an actively dying, unarousable patient.
Severe neuropathic pain secondary to a malignant tumor compressing a spinal nerve root.
Severe terminal delirium characterized by acute agitation and distressing visual hallucinations.

Matches

Show answer & explanation

Answer

Terminal dyspnea is managed with morphine; noisy respiratory secretions with anticholinergics like hyoscyamine; neuropathic pain with gabapentinoids; and terminal delirium with neuroleptics like haloperidol.
Each specific palliative symptom pairs with a targeted pharmacological class: opioids for air hunger, anticholinergics for pooled secretions, nerve-stabilizing agents for radicular/neuropathic pain, and dopamine antagonists for hyperactive delirium.

Step-by-Step Solution

1
Evaluate the management of terminal dyspnea.
Identify that low-dose morphine is the appropriate choice to decrease air hunger.
Opioids reduce the sensitivity of the medullary respiratory center to hypercapnia.
2
Evaluate the management of noisy respiratory secretions.
Identify that hyoscyamine or glycopyrrolate is the appropriate choice.
Anticholinergics reduce the production of saliva and respiratory secretions that pool in the airway of obtunded patients.
3
Evaluate the management of neuropathic pain.
Identify that gabapentin or pregabalin is the appropriate choice.
Neuropathic pain is often opioid-resistant and requires nerve-stabilizing adjuvants.
4
Evaluate the management of hyperactive terminal delirium.
Identify that haloperidol is the appropriate choice.
Neuroleptics safely manage severe agitation and psychotic symptoms at the end of life.

Key Concept

First-line pharmacologic symptom management in palliative care.
Question 831Question →

During morning rounds, a physician discusses discharge plans with a hospitalized patient. The patient is a 67-year-old man admitted two days prior for new-onset atrial fibrillation with rapid ventricular response. His heart rate is now well-controlled. His medical history includes hypertension, type 2 diabetes mellitus, and osteoarthritis, for which he takes lisinopril, metformin, and over-the-counter naproxen. The physician explains the need to start an oral anticoagulant for stroke prevention. Upon hearing this, the patient crosses his arms, becomes visibly tense, and says, "My older brother was put on a blood thinner. Six months later, he had a massive brain hemorrhage and died. I am not taking that poison. I will just keep taking my naproxen; I have heard it thins the blood anyway." Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: It sounds like your brother's passing was a traumatic experience. Can you share more about what you went through during that time?

Answer

The most appropriate initial response is to empathetically acknowledge the patient's traumatic experience regarding his brother and ask an open-ended question to explore his feelings further.
The correct answer acknowledges the patient's emotional distress and uses an open-ended question to explore his underlying fears. When a patient expresses strong emotions or resistance tied to a past traumatic event involving a family member, the most effective communication strategy is to first validate the emotion and explore the patient's perspective. Attempting to correct medical misconceptions, quote guidelines, or offer alternative treatments prematurely will likely heighten the patient's defensiveness and damage the therapeutic alliance.

Step-by-Step Solution

1
Analyze the patient's statement and emotional state.
The patient is expressing strong fear and resistance to a recommended therapy based on a family member's traumatic outcome.
Identifying the root cause of the patient's refusal (strong emotion and trauma versus a simple factual misunderstanding) dictates the appropriate communication strategy.
2
Evaluate the proposed physician responses against patient-centered communication principles.
The optimal response must prioritize empathy and exploration over medical education, confrontation, or negotiation.
The therapeutic alliance must be established and emotions must be validated before a patient is receptive to medical facts or shared decision-making.
3
Select the response that utilizes an open-ended question to explore the patient's grief.
The option asking the patient to share more about his brother's experience is the only one that directly addresses the emotional core.
This aligns with the 'Explore' and 'Understand' components of the NURSE framework for empathetic communication.

Key Concept

Patient-centered communication: prioritizing empathetic exploration of patient fears and illness narratives before correcting medical misconceptions.
Question 832Question →

An established 62-year-old female patient presents for an annual health maintenance visit. Her active medical problems include Crohn disease (currently maintained on infliximab) and type 2 diabetes mellitus. She smoked one pack of cigarettes daily from age 20 to 50 but quit 12 years ago (30 pack-year history). Her mother was diagnosed with breast cancer at age 70.

Her preventive care history includes the following:
- Screening mammography 11 months ago, which was interpreted as normal
- Total abdominal hysterectomy with bilateral salpingo-oophorectomy at age 45 for symptomatic uterine fibroids
- Colonoscopy 4 years ago, which revealed a single 6-mm tubular adenoma

Her immunizations for influenza, COVID-19, and tetanus-diphtheria-acellular pertussis (Tdap) are up to date. She has never received a zoster vaccine.

Which of the following preventive interventions are indicated for this patient during today's visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Annual low-dose computed tomography (LDCT) of the chest; Recombinant zoster vaccine

Answer

The correct interventions are annual low-dose computed tomography (LDCT) of the chest and the recombinant zoster vaccine.
The patient meets current criteria for lung cancer screening with annual low-dose computed tomography (LDCT), as she falls within the 50 to 80 age range, has a ≥20\geq 20 pack-year smoking history, and quit within the last 15 years. The recombinant zoster vaccine is also indicated, as it is recommended for all adults aged 50 and older, regardless of prior herpes zoster episodes. Furthermore, her use of infliximab represents an immunocompromising condition, making the non-live recombinant zoster vaccine highly indicated and safe to administer.

Step-by-Step Solution

1
Evaluate criteria for lung cancer screening.
LDCT is indicated.
The patient is between 50 and 80 years of age, has a 30 pack-year smoking history, and quit within the last 15 years (quit 12 years ago).
2
Evaluate immunization requirements based on age and comorbidities.
Recombinant zoster vaccine is indicated.
She is over 50 years old and has never received it. Additionally, her use of infliximab (a TNF inhibitor) makes her immunosuppressed, independently qualifying her for the recombinant (non-live) zoster vaccine.
3
Analyze intervals for breast, cervical, and colorectal cancer screenings.
None of these are currently indicated.
Breast cancer screening is biennial (hers was 11 months ago). Cervical screening is discontinued after benign hysterectomy. Colorectal surveillance for a single low-risk adenoma is at 7-10 years, with no interval FIT testing.

Key Concept

Application of multiple concurrent, evidence-based preventive screening guidelines and immunization schedules in an adult with specific risk factors and complex medical history.
Question 833Question →

A 55-year-old woman presents to the clinic for a follow-up visit. Three months ago, she was diagnosed with an unprovoked pulmonary embolism and was started on rivaroxaban. One month ago, she experienced an episode of melena and was diagnosed with a small gastric ulcer, which is currently healing well on a daily proton pump inhibitor. Today, the patient appears anxious. She states, "I read online that these blood thinners can cause fatal stomach bleeding. I want to stop the rivaroxaban immediately and just take a daily aspirin instead. To help manage my anxiety naturally, I recently started taking a daily St. John's wort supplement." The patient's vital signs and physical examination are unremarkable. Which of the following is the most appropriate initial counseling statement by the physician?

Show answer & explanation

Answer: I understand your concerns about bleeding, but stopping your anticoagulant significantly increases your risk for another blood clot; additionally, St. John's wort can reduce the effectiveness of your current blood thinner.

Answer

The statement validating the patient's bleeding concerns while educating her that stopping anticoagulation increases thrombosis risk and that St. John's wort reduces the anticoagulant's efficacy.
The correct response utilizes the foundational communication skill of validating the patient's emotional concern (fear of recurrent gastrointestinal bleeding) before delivering essential medical education. It correctly identifies that discontinuing rivaroxaban prematurely—or replacing it with aspirin, which is vastly inferior for VTE prevention—places the patient at high risk for a recurrent unprovoked pulmonary embolism. Furthermore, it accurately educates the patient on a critical pharmacokinetic interaction: St. John's wort is a potent inducer of both CYP3A4 and P-glycoprotein. Coadministration increases the metabolism and efflux of rivaroxaban, thereby decreasing its serum concentration and putting the patient at an even greater risk for therapeutic failure and thrombosis.

Step-by-Step Solution

1
Evaluate the patient's clinical status and her request to stop rivaroxaban for an unprovoked pulmonary embolism at 3 months.
Unprovoked PE typically requires at least 3 to 6 months of anticoagulation, often indefinitely. Stopping now or switching to aspirin carries a high risk of recurrent thrombosis.
Standard medical guidelines mandate DOAC therapy over aspirin for the secondary prevention of venous thromboembolism.
2
Analyze the drug-supplement interaction between rivaroxaban and St. John's wort.
St. John's wort is a strong CYP3A4 and P-glycoprotein inducer, which significantly decreases rivaroxaban plasma levels.
This pharmacokinetic interaction increases the risk of therapeutic failure and recurrent blood clots, which the patient must be educated about.
3
Formulate the most appropriate patient counseling statement based on communication best practices.
The physician must empathetically validate the patient's emotional fears (gastric bleeding), correct the misconception about aspirin equivalence, and explicitly warn her about the dangerous herbal supplement interaction.
Effective patient health education requires addressing emotional barriers while providing accurate, evidence-based medical facts.

Key Concept

Patient counseling on VTE management, drug-herb interactions (CYP3A4 inducers), and addressing medical misconceptions.
Question 834Question →

An attending physician is observing a medical resident conduct preventive counseling for tobacco cessation. The resident encounters patients in various stages of readiness to quit smoking. Match each patient statement (representing a specific stage of the transtheoretical model of change) to the most appropriate next step in physician counseling.

Click a left item, then click its matching right item

Items

"I only smoke a few cigarettes a day, and it is definitely not the reason my asthma is flaring up."
"I know smoking is making my breathing worse, but I am terrified of gaining weight if I stop."
"I plan to stop smoking completely by the first of next month, and I told my family about it."
"It has been 14 days since my last cigarette, though the urges after meals are still very intense."

Matches

Show answer & explanation

Answer

The statement denying the link to asthma matches with asking for permission to provide information. The statement expressing fear of weight gain matches with exploring pros and cons. The statement about stopping next month matches with finalizing a concrete plan. The statement about being smoke-free for 14 days matches with brainstorming alternative activities.
Effective health education and counseling require tailoring the physician's intervention to the patient's current readiness to change, as described by the Transtheoretical Model. Precontemplation requires raising awareness without pressure. Contemplation requires exploring ambivalence (pros and cons). Preparation requires establishing a firm plan and offering tangible resources. Action requires support for relapse prevention.

Step-by-Step Solution

1
Identify the stage of change for the patient denying the link between smoking and asthma.
This patient is in Precontemplation.
This determines that the goal is to build awareness and establish rapport, not force immediate action.
2
Identify the stage of change for the patient terrified of weight gain.
This patient is in Contemplation (weighing benefits against fears).
This indicates the need to explore ambivalence and tip the decisional balance toward change.
3
Identify the stage of change for the patient planning to stop next month.
This patient is in Preparation (took initial steps and set a timeframe).
This shows readiness for concrete logistical planning and pharmacologic support.
4
Identify the stage of change for the patient who quit 14 days ago.
This patient is in Action.
This stage requires targeted relapse prevention strategies and positive reinforcement.

Key Concept

Transtheoretical Model of Change in Patient Counseling
Question 835Question →

An active 68-year-old man visits his primary care provider for an annual wellness check. He has a medical history significant for type 2 diabetes mellitus and primary hypertension. During the visit, the clinician notes that the patient has never received a pneumococcal vaccination. Upon offering the 20-valent pneumococcal conjugate vaccine (PCV20), the patient immediately shakes his head and states, 'I am not getting that. My brother got a pneumonia shot last winter and was hospitalized with severe pneumonia just three days later. That shot obviously gave him the disease!' Which of the following is the most appropriate response by the clinician?

Show answer & explanation

Answer: I appreciate your concern about your brother's experience, but this vaccine only contains bacterial fragments and cannot cause a pneumonia infection.

Answer

Acknowledge the patient's concern and explain that the pneumococcal vaccine is inactivated and cannot cause a pneumonia infection.
The correct response actively listens to the patient's fear, validates his concern about his brother, and directly addresses the misconception with a clear medical fact. The pneumococcal vaccine is an inactivated (non-live) vaccine containing bacterial capsular polysaccharides. It cannot cause an active pneumococcal infection. Patient education should focus on correcting specific knowledge gaps without being confrontational or dismissive.

Step-by-Step Solution

1
Identify the patient's core concern and educational gap.
The patient erroneously believes that the pneumococcal vaccine can cause an active pneumonia infection because of a temporal association in his brother's case.
Understanding the specific barrier to care allows for targeted counseling.
2
Determine the appropriate counseling strategy.
The clinician must validate the patient's emotional concern while correcting the medical misconception.
Effective health education requires empathy and clear, factual information.
3
Apply the correct medical facts about the vaccine.
The pneumococcal vaccine (PCV20 or PPSV23) does not contain live organisms; it is composed of purified capsular polysaccharides (conjugated to a carrier protein in PCV20). Therefore, it is biologically impossible for it to cause pneumococcal pneumonia.
Accurate patient education directly addresses vaccine hesitancy.

Key Concept

Patient Counseling and Health Education
Question 836Question →

A 60-year-old man comes to the outpatient clinic for a routine wellness visit. His past medical history is significant for hyperlipidemia, mild cognitive impairment, and osteoarthritis. His current medications include atorvastatin and daily naproxen. His wife accompanies him to the appointment. A review of his medical record indicates that he is due for colorectal cancer screening, as his only previous colonoscopy was performed 11 years ago and was normal.

When the physician recommends scheduling a screening colonoscopy, the patient becomes visibly agitated and refuses. He states, "My neighbor had a major bleed and almost died after that procedure. I'm perfectly healthy. In fact, I recently started taking Ginkgo biloba to improve my memory and blood flow, along with my naproxen. I don't need any invasive tests."

The patient is alert, oriented, and correctly verbalizes an understanding of the potential consequences of not undergoing the screening. His wife privately asks the physician to schedule the procedure anyway, stating she is his healthcare proxy and will ensure he attends the appointment.

Which of the following is the most appropriate next step in counseling and managing this patient?

Show answer & explanation

Answer: Validate the patient's concerns about the procedure, respect his refusal, and educate him regarding the increased bleeding risk of combining his current medications and supplements.

Answer

The correct approach is to validate the patient's anxiety, respect his informed refusal since he maintains decision-making capacity, and immediately counsel him on the bleeding hazards of concomitantly using naproxen and Ginkgo biloba.
The correct action demonstrates appropriate patient counseling and management by balancing respect for autonomy with the physician's duty to educate. The patient demonstrates clinical capacity because he understands his situation and the consequences of his refusal. Therefore, his refusal must be respected, and his wife cannot act as a surrogate. Additionally, the physician must seize the educational opportunity to counsel the patient about the well-documented increased risk of bleeding when combining an NSAID (naproxen) with Ginkgo biloba.

Step-by-Step Solution

1
Evaluate the patient's clinical decision-making capacity.
The patient is alert, oriented, and accurately verbalizes the consequences of his refusal, indicating intact capacity.
A patient with intact capacity has the ethical and legal right to refuse medical interventions, regardless of the presence of mild cognitive impairment or disagreeing family members.
2
Determine the role of the healthcare proxy in this scenario.
The wife's request to schedule the procedure against the patient's will cannot be honored.
Surrogate decision-makers are only activated when a patient lacks clinical decision-making capacity.
3
Assess the patient's self-reported medication and supplement regimen for safety issues.
The combination of Ginkgo biloba and naproxen poses a significant bleeding risk.
Both agents impair platelet aggregation and increase hemorrhage risk; the physician has a duty to provide health education on this specific pharmacological interaction.
4
Formulate the most appropriate patient counseling and management strategy.
The physician should employ patient-centered counseling to validate his fears, accept his refusal, and provide vital health education regarding his medication risks.
This approach respects patient autonomy, builds therapeutic trust, and addresses an immediate, preventable patient safety concern.

Key Concept

Respecting patient autonomy in the setting of informed refusal while providing essential health education regarding dangerous drug-supplement interactions.
Question 837Question →

A 71-year-old man with severe anoxic brain injury following a prolonged cardiac arrest is in the intensive care unit. Neurological evaluation confirms a dismal prognosis for meaningful recovery. Following extensive discussions with his family, they decide to transition his care to comfort measures only, which includes withdrawal of mechanical ventilation.

Arrange the following steps for palliative ventilator withdrawal in the most appropriate chronological order to ensure ethical compliance and optimize patient comfort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for palliative ventilator withdrawal is: 1) Document a DNR order and goals of care; 2) Silence alarms and prepare the environment; 3) Administer preemptive bolus doses of opioids and benzodiazepines; 4) Deflate the cuff and withdraw the endotracheal tube; 5) Assess for post-extubation distress and titrate medications.
Palliative ventilator withdrawal requires a structured approach to optimize patient comfort and support the family. The first mandatory step is formally documenting a do-not-resuscitate (DNR) order and confirming goals of care to prevent unwanted resuscitation. Second, the environment must be prepared by silencing physiological monitor alarms to create a peaceful setting and avoid family distress as vital signs decline. Third, prophylactic symptom management with opioids and benzodiazepines must be administered prior to tube removal to preempt the expected surge of dyspnea or agitation. Only after the patient is adequately pre-medicated is the endotracheal tube actually withdrawn. Finally, immediate post-extubation assessment is necessary to identify and treat any emergent distress rapidly with continuous infusions.

Step-by-Step Solution

1
Establish ethical and legal prerequisites
DNR order is documented and comfort goals are confirmed
Prevents inappropriate resuscitation attempts during or after the withdrawal process.
2
Prepare the patient and environment
Monitoring alarms are silenced
Eliminates technological noise that causes emotional distress to the family without offering any clinical benefit.
3
Administer prophylactic symptom management
Intravenous opioids and benzodiazepines are given
Preempts the expected surge of dyspnea, coughing, or agitation that frequently occurs immediately upon extubation.
4
Perform the extubation
Endotracheal cuff is deflated and tube is removed
Completes the withdrawal of mechanical ventilation once the patient is properly prepared and medicated.
5
Provide post-extubation care
Patient is assessed for distress and infusions are titrated
Ensures ongoing comfort as the patient transitions to spontaneous breathing or approaches death.

Key Concept

Palliative ventilator withdrawal sequence
Question 838Question →

Match each patient statement, which reflects a specific cognitive barrier or health belief, to the most appropriate initial physician counseling response.

Click a left item, then click its matching right item

Items

"I'm not giving my child the MMR vaccine. It's much safer to let him get the measles naturally than for me to actively inject him with something that might cause a severe reaction."
"I know I should use the CPAP machine, but the mask is annoying. I'll just deal with the heart problems in the future if they ever happen."
"My grandfather smoked and lived to 90. I have his genetics, so I'm not worried about my lungs, even though I can't play basketball like I used to because I get winded."
"Every time I think about taking a new pill, my stomach turns. I just know if I take this medication, I'll get every terrible side effect listed on the bottle."
"I only read articles from holistic forums because mainstream medicine is paid by pharmaceutical companies to hide the truth about statins."

Matches

Show answer & explanation

Answer

The patient statements should be matched to the physician responses that directly address their specific underlying cognitive biases and psychological barriers: Omission Bias, Temporal Discounting, Optimism Bias (Discrepancy), Nocebo Effect, and Reactance.
Each correct pairing optimally aligns a specific psychological barrier with its corresponding evidence-based communication strategy. The MMR vaccine statement demonstrates Omission Bias, which is best addressed by directly comparing the risks of action versus inaction. The CPAP statement shows Temporal Discounting, addressed by emphasizing immediate short-term benefits. The smoking statement contains a value-behavior conflict, optimally addressed by the Motivational Interviewing technique of Developing Discrepancy. The medication anxiety statement reflects Nocebo Anticipation, managed by validating the mind-body connection and starting at a very low dose. Finally, the statin statement shows Reactance and Distrust, which requires Rolling with Resistance and asking permission before sharing data.

Step-by-Step Solution

1
Analyze the statement regarding the MMR vaccine.
Identified 'Omission Bias'—the cognitive distortion that harm caused by an action is worse than harm caused by inaction.
Recognizing this specific bias is necessary to select the communication strategy that acknowledges the fear of action while reframing the risk.
2
Analyze the CPAP patient statement.
Identified 'Temporal Discounting' (Present Bias)—prioritizing immediate comfort over long-term risk reduction.
Requires a strategy that bridges the temporal gap by highlighting immediate, short-term benefits.
3
Analyze the smoker's statement.
Identified 'Optimism Bias' mixed with a value-behavior conflict (wants to play basketball but smokes).
Motivational interviewing's 'Developing Discrepancy' is the ideal tool to gently highlight this conflict without triggering defensiveness.
4
Analyze the statement about anticipating medication side effects.
Identified 'Nocebo Anticipation'—where anxiety creates actual somatic symptoms.
Requires validating the mind-body connection and offering a high-control, low-risk strategy to reduce the patient's anxiety.
5
Analyze the statement regarding pharmaceutical distrust.
Identified 'Reactance' and profound distrust of the medical establishment.
Requires 'Rolling with Resistance' and supporting autonomy before any objective data can be successfully introduced.

Key Concept

Matching specific communication strategies to underlying patient cognitive biases and psychological barriers.
Question 839Question →

Match each patient's clinical scenario with the most appropriate guideline-concordant preventive care and screening strategy.

Click a left item, then click its matching right item

Items

During a routine health maintenance evaluation, a 68-year-old female patient reports a past medical history significant for cervical intraepithelial neoplasia grade 2 (CIN-2) that was definitively treated at age 55. Her last Pap and HPV cotesting performed at age 64 yielded negative results.
Evaluation of a 75-year-old male with severe, oxygen-dependent chronic obstructive pulmonary disease reveals a remote 40 pack-year smoking history prior to quitting 8 years ago.
A 42-year-old asymptomatic male provides an updated family pedigree revealing that his father was diagnosed with colorectal cancer at 50 years of age.
Following a new diagnosis of HIV infection, a 32-year-old male with a baseline CD4 count of 450 cells/mm³ is reviewed for immunization deficits. He has not received any vaccinations since adolescence.
A healthy 35-year-old female of Ashkenazi Jewish descent inquires about cancer risk mitigation after discovering her paternal grandmother succumbed to ovarian cancer at age 65.

Matches

Show answer & explanation

Answer

The clinical scenarios map to highly specific guideline exceptions: extending cervical screening for 25 years post-CIN-2, stopping LDCT due to limited surgical candidacy, accelerating colorectal screening to a 5-year interval starting at age 40 due to high-risk family history, administering PCV20 for new-onset HIV, and referring for BRCA genetic counseling based on Ashkenazi ancestry and second-degree family history.
Each correct pairing represents a critical nuance in preventive care guidelines where standard, average-risk protocols are overridden by specific historical, demographic, or physiologic factors.

Step-by-Step Solution

1
Evaluate the 68-year-old female's cervical cancer screening cessation criteria.
Determine that routine age-based cessation does not apply.
The history of CIN-2 treated at age 55 triggers a 25-year post-treatment surveillance mandate, requiring screening to continue until at least age 80.
2
Analyze the 75-year-old male's eligibility for lung cancer screening with LDCT.
Determine that LDCT is contraindicated despite his qualifying 40 pack-year smoking history.
Guidelines mandate cessation of LDCT if the patient develops a health problem (like end-stage COPD on continuous oxygen) that limits life expectancy or the ability to undergo curative surgery.
3
Assess the 42-year-old male's colorectal cancer screening requirements.
Determine he requires immediate screening with an accelerated follow-up interval.
Having a first-degree relative diagnosed with colorectal cancer at age 50 dictates starting screening at age 40 (10 years prior to the relative's diagnosis) and repeating the colonoscopy every 5 years.
4
Identify the adult immunization needs for the 32-year-old male with HIV.
Determine he requires pneumococcal vaccination.
HIV is an immunocompromising condition that necessitates pneumococcal immunization (PCV20) in adults under age 65.
5
Evaluate the 35-year-old female's genetic screening risk.
Determine she meets criteria for formal BRCA risk assessment.
Ashkenazi Jewish descent combined with a second-degree relative's history of ovarian cancer is a high-risk profile warranting genetic counseling.

Key Concept

Advanced application of USPSTF and ACIP preventive guidelines, focusing on high-risk demographic modifiers, age-based exceptions, and comorbidity-driven cessation criteria.
Question 840Question →

A 78-year-old man with advanced idiopathic pulmonary fibrosis and cor pulmonale is enrolled in home hospice care. His functional status has declined rapidly over the past two weeks, and he is now entirely bedbound. He has an active do-not-resuscitate (DNR) and do-not-intubate (DNI) order in place. Over the last 24 hours, he has experienced progressively worsening shortness of breath. His respiratory rate is 28/min, and his oxygen saturation is 86% on 4 L/min via nasal cannula. He appears distressed, agitated, and is using accessory muscles of respiration. The hospice nurse arrives to evaluate the patient and optimize his symptom management.

Arrange the following interventions in the most appropriate stepwise sequence for escalating the management of this patient's terminal dyspnea, assuming each preceding step has been maximized but failed to provide adequate symptomatic relief.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct stepwise escalation for terminal dyspnea management is: (1) Non-pharmacologic interventions, (2) Immediate-release oral/sublingual opioids, (3) Continuous parenteral opioid infusion, (4) Addition of an adjunctive benzodiazepine, and (5) Palliative sedation.
The management of terminal dyspnea follows a stepwise escalation based on symptom severity and response to treatment. Non-pharmacologic measures (e.g., cool air via a fan, elevating the head of the bed) are the safest initial step. Opioids are the gold standard first-line pharmacologic treatment for dyspnea, typically started as low-dose immediate-release formulations. If symptoms persist or the patient loses the ability to swallow, transitioning to a continuous parenteral opioid infusion is indicated. If dyspnea remains refractory and is accompanied by prominent anxiety or panic, adding an adjunctive benzodiazepine is appropriate. Finally, if the patient experiences intractable, refractory suffering despite maximized medical therapy, palliative sedation (intentional lowering of consciousness) is the universally accepted treatment of last resort.

Step-by-Step Solution

1
Identify the primary clinical challenge and care context.
The patient is experiencing severe, escalating terminal dyspnea in a home hospice setting.
Recognizing the end-of-life context and DNR/DNI status dictates a purely symptom-directed, palliative approach rather than disease-modifying or invasive therapy.
2
Determine the safest initial non-pharmacologic approach.
Positioning and utilizing a bedside fan to direct cool air to the face.
These interventions carry zero risk, are immediately available, and effectively stimulate trigeminal afferents to reduce the central sensation of breathlessness.
3
Establish the first-line pharmacologic standard of care.
Initiation of low-dose immediate-release opioids.
Opioids are the most effective pharmacologic treatment for dyspnea, acting to decrease the central respiratory drive and alter the subjective perception of breathlessness.
4
Determine the escalation strategy if initial pharmacologic steps fail to provide relief.
Transition to continuous parenteral opioids, then add benzodiazepines, and finally consider palliative sedation as a last resort.
Continuous infusions provide steady-state relief. Benzodiazepines address the anxiety/panic cycle that exacerbates dyspnea. Palliative sedation is strictly reserved for when all other therapies fail to relieve unbearable suffering.

Key Concept

The stepwise management of refractory terminal dyspnea prioritizes non-pharmacologic measures, followed by opioids (the gold standard pharmacologic therapy), adjunctive anxiolytics for associated panic, and palliative sedation as a final resort.
PreviousPage 42 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 42 | Examkin